Found: 3
Select item for more details and to access through your institution.
Pharmacokinetics, pharmacodynamics, and safety of GS‐3583, a FLT3 agonist Fc fusion protein, from single‐ascending‐dose phase I study in healthy participants.
- Published in:
- CTS: Clinical & Translational Science, 2024, v. 17, n. 8, p. 1, doi. 10.1111/cts.70011
- By:
- Publication type:
- Article
The Relative Bioavailability and Effects of Food and Acid‐Reducing Agents on Filgotinib Tablets in Healthy Subjects.
- Published in:
- Clinical Pharmacology in Drug Development, 2019, v. 8, n. 5, p. 585, doi. 10.1002/cpdd.659
- By:
- Publication type:
- Article
Organic Anion Transporting Polypeptide Inhibition Dramatically Increases Plasma Exposure but not Pharmacodynamic Effect nor Inferred Hepatic Intracellular Exposure of Firsocostat.
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 109, n. 5, p. 1334, doi. 10.1002/cpt.2105
- By:
- Publication type:
- Article